A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Lilly

Status and phase: Completed; Phase 4

Conditions: Diabetes Mellitus, Type 2

Treatments: Drug: Semaglutide Pen; Drug: Dulaglutide Pen

Study type: Interventional

Funder types: Industry

Identifiers

NCT03724981

H9X-MC-B021 (Other Identifier)

17155

Details and patient eligibility

About

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Enrollment: 312 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with type 2 diabetes
• Self-injection naïve to all injectable treatment (for example, diabetes therapies and other medical conditions)
• Injection naïve to performing all injectable treatment (for example, diabetes therapies and other medical conditions) to others

Exclusion criteria

• Currently diagnosed with gestational diabetes and/or type 1 diabetes
• Cognitive or physical difficulties that could interfere with ability to understand the training, perform the injection tasks, or complete the study questionnaires as judged by the investigator
• Is a health care practitioner who is trained in giving injections

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

312 participants in 2 patient groups

Dulaglutide Pen

Experimental group

Description:

Injection of commercial dulaglutide pen on a practice pad.

Treatment:

Drug: Dulaglutide Pen

Semaglutide Pen

Experimental group

Description:

Injection of commercial semaglutide pen on a practice pad.

Treatment:

Drug: Semaglutide Pen